Company intelligence / Profile preview

Prescient Metabiomics

Carlsbad, California, United States
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Prescient Metabiomics has developed LifeKit PREVENT, a non‑invasive stool‑based microbiome diagnostic test for colorectal neoplasia that has received FDA Breakthrough Device designation for detecting both colorectal cancer and precancerous adenomas, with clinical research suggesting >80% accuracy for detecting precancerous colon polyps[8][9].

Therapeutic areas
OncologyGastroenterology
Modalities
Diagnostic testIn-vitro diagnostic
Industry
Molecular Diagnostics
02

Partnerships

CoreBiome (OraSure Technologies subsidiary) – collaboration on metagenomic sequencing and analytics for LifeKit PREVENT colorectal cancer screening test[1].Harvard T.H. Chan School of Public Health Microbiome in Public Health Center – research collaboration on microbial biomarkers for colon cancer screening[2][7].Prescient Medicine/SOLVD Health – joint venture and ongoing integration to develop microbiome-based GI health diagnostics including LifeKit PREVENT[3][8][11].Multiple academic medical centers (e.g., George Mason University, Rush University Medical Center, Virginia Commonwealth University, Case Western Reserve University, University of Calgary, Mayo Clinic, Boston University) for microbiome clinical research in gastrointestinal diseases[4].

Beyond the preview

Go deeper on Prescient Metabiomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prescient Metabiomics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call